Dairong Li

机构：The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0002-7524-0733

发表论文 32 篇 · 总被引 456 次 · h-index 13

代表论文

Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial (2025 · The Lancet · 被引 33)
Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression (2018 · Journal of Cellular Physiology · 被引 26)
<p>Circular RNA MYLK Promotes Glycolysis and Proliferation of Non-Small Cell Lung Cancer Cells by Sponging miR-195-5p and Increasing Glucose Transporter Member 3 Expression</p> (2020 · Cancer Management and Research · 被引 25)
Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection (2018 · Cancer Biomarkers · 被引 24)
Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway (2018 · Cellular Physiology and Biochemistry · 被引 24)
Hsa_circ_0101996 combined with hsa_circ_0101119 in peripheral whole blood can serve as the potential biomarkers for human cervical squamous cell carcinoma. (2017 · PubMed · 被引 22)